Pesquisa | BVS Integralidade em Saúde

1.

An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

Zhu, Zewu; Bo-Ran Ho, Bryan; Chen, Alyssa; Amrhein, James; Apetrei, Andreea; Carpenter, Thomas Oliver; Lazaretti-Castro, Marise; Colazo, Juan Manuel; McCrystal Dahir, Kathryn; Geßner, Michaela; Gurevich, Evgenia; Heier, Cathrine Alsaker; Simmons, Jill Hickman; Hunley, Tracy Earl; Hoppe, Bernd; Jacobsen, Christina; Kouri, Anne; Ma, Nina; Majumdar, Sachin; Molin, Arnaud; Nokoff, Natalie; Ott, Susan M; Peña, Helena Gil; Santos, Fernando; Tebben, Peter; Topor, Lisa Swartz; Deng, Yanhong; Bergwitz, Clemens.

Kidney Int ; 105(5): 1058-1076, 2024 May.

Artigo em Inglês | MEDLINE | ID: mdl-38364990

2.

Osteoporosis and Fracture Risk among Older US Asian Adults.

Lo, Joan C; Yang, Wei; Park-Sigal, Jennifer J; Ott, Susan M.

Curr Osteoporos Rep ; 21(5): 592-608, 2023 10.

Artigo em Inglês | MEDLINE | ID: mdl-37542683

3.

In osteoporosis or osteopenia, exercise interventions improve BMD; effects vary by exercise type and BMD site.

Ott, Susan M.

Ann Intern Med ; 175(4): JC46, 2022 04.

Artigo em Inglês | MEDLINE | ID: mdl-35377720

4.

In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk.

Ott, Susan M.

Ann Intern Med ; 174(1): JC9, 2021 01.

Artigo em Inglês | MEDLINE | ID: mdl-33395342

5.

Not etched in bone: the role of osteoclast proton-sensing receptors.

Ott, Susan M.

Kidney Int ; 99(3): 542-545, 2021 03.

Artigo em Inglês | MEDLINE | ID: mdl-33637200

6.

Importance of bone turnover for therapeutic decisions in patients with CKD-MBD.

Ott, Susan M; Malluche, Hartmut H; Jorgetti, Vanda; Elder, Grahame J.

Kidney Int ; 100(3): 502-505, 2021 09.

Artigo em Inglês | MEDLINE | ID: mdl-34420656

7.

Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Bar, Merav; Ott, Susan M; Lewiecki, E Michael; Sarafoglou, Kyriakie; Wu, Joy Y; Thompson, Matthew J; Vaux, Jonathan J; Dean, David R; Saag, Kenneth G; Hashmi, Shahrukh K; Inamoto, Yoshihiro; Dholaria, Bhagirathbhai R; Kharfan-Dabaja, Mohamed A; Nagler, Arnon; Rodriguez, Cesar; Hamilton, Betty K; Shah, Nina; Flowers, Mary E D; Savani, Bipin N; Carpenter, Paul A.

Biol Blood Marrow Transplant ; 26(10): 1784-1802, 2020 10.

Artigo em Inglês | MEDLINE | ID: mdl-32653624

8.

Structural and Metabolic Assessment of Bone.

Narla, Radhika R; Ott, Susan M.

Handb Exp Pharmacol ; 262: 369-396, 2020.

Artigo em Inglês | MEDLINE | ID: mdl-32885312

9.

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.

Lo, Joan C; Neugebauer, Romain S; Ettinger, Bruce; Chandra, Malini; Hui, Rita L; Ott, Susan M; Grimsrud, Christopher D; Izano, Monika A.

BMC Musculoskelet Disord ; 21(1): 801, 2020 Dec 03.

Artigo em Inglês | MEDLINE | ID: mdl-33272248

10.

Renal insufficiency and bone loss.

Ott, Susan M.

Curr Opin Rheumatol ; 31(4): 394-399, 2019 07.

Artigo em Inglês | MEDLINE | ID: mdl-31135568

11.

Osteoporosis Treatment: Not Easy.

Ott, Susan M.

Ann Intern Med ; 176(2): 278-279, 2023 02.

Artigo em Inglês | MEDLINE | ID: mdl-36592468

12.

Bones and the sex hormones.

Narla, Radhika R; Ott, Susan M.

Kidney Int ; 94(2): 239-242, 2018 08.

Artigo em Inglês | MEDLINE | ID: mdl-30031443

13.

Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.

Ott, Susan M; Heckbert, Susan R.

N Engl J Med ; 383(22): 2188-2189, 2020 11 26.

Artigo em Inglês | MEDLINE | ID: mdl-33252881

14.

Renal Osteodystrophy-Time for Common Nomenclature.

Ott, Susan M.

Curr Osteoporos Rep ; 15(3): 187-193, 2017 06.

Artigo em Inglês | MEDLINE | ID: mdl-28466454

15.

Bone strength: more than just bone density.

Ott, Susan M.

Kidney Int ; 89(1): 16-9, 2016 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-26759040

16.

Role of proton receptor OGR1 in bone response to metabolic acidosis?

Jorgetti, Vanda; Drüeke, Tilman B; Ott, Susan M.

Kidney Int ; 89(3): 529-31, 2016 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-26880446

17.

Bone cells, sclerostin, and FGF23: what's bred in the bone will come out in the flesh.

Ott, Susan M.

Kidney Int ; 87(3): 499-501, 2015 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-25723633

18.

Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease.

Ott, Susan M.

Semin Dial ; 28(4): 363-9, 2015.

Artigo em Inglês | MEDLINE | ID: mdl-25940768

19.

Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD.

Jorgetti, Vanda; dos Reis, Luciene M; Ott, Susan M.

Kidney Int ; 85(6): 1283-9, 2014 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-24352156

20.

Postmenopausal Osteoporosis.

Ott, Susan M.

N Engl J Med ; 374(21): 2095-6, 2016 05 26.

Artigo em Inglês | MEDLINE | ID: mdl-27223159

BVS Integralidade em Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

Osteoporosis and Fracture Risk among Older US Asian Adults.

In osteoporosis or osteopenia, exercise interventions improve BMD; effects vary by exercise type and BMD site.

In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk.

Not etched in bone: the role of osteoclast proton-sensing receptors.

Importance of bone turnover for therapeutic decisions in patients with CKD-MBD.

Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Structural and Metabolic Assessment of Bone.

Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.

Renal insufficiency and bone loss.

Osteoporosis Treatment: Not Easy.

Bones and the sex hormones.

Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.

Renal Osteodystrophy-Time for Common Nomenclature.

Bone strength: more than just bone density.

Role of proton receptor OGR1 in bone response to metabolic acidosis?

Bone cells, sclerostin, and FGF23: what's bred in the bone will come out in the flesh.

Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease.

Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD.

Postmenopausal Osteoporosis.